Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-15

Clinical Trial Update: Switching to Iloperidone From Other Antipsychotics in Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating switching schizophrenia patients from other antipsychotics to iloperidone; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Iloperidone (iloperidone)

Snippet

Sponsor: Novartis | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2013-03-15